DCA Vantage Analyzer
Drive diabetic patient compliance with trusted, clinically proven results
DCA Vantage Analyzer
Watch animation
New 2-D barcode scanner.
Actionable results in 7 minutes or less
Minimize the need for follow-up visits with a full spectrum of results: HbA1c (NGSP certified and IFCC certified/CLIA waived), Estimated Average Glucose*, Albumin, Creatinine, and Albumin-to-Creatinine Ratio results.
*Not available in the US
Easy to use in the office or clinic
No sample or reagent preparation is required, and the system provides versatile data management and reporting options
Robust technology delivers proven performance
The analyzer leverages robust technology and delivers the proven performance of the DCA HbA1c and DCA Microalbumin/Creatinine tests highlighted in more than 140 clinical articles.
Manage diabetes testing in decentralized settings
Powerful functionality enables POC coordinators to better manage diabetes testing in decentralized settings. When supported by Siemens RAPIDComm® Data Management System, coordinators can oversee and troubleshoot multiple connected analyzers in real time.
The DCA Vantage Analyzer is a point-of-care system that helps you monitor glycemic control and detect early kidney disease.
• CLIA-waived HbA1c test that is IFCC and NGSP-certified
• 1µl finger stick without fasting – HbA1c results in 6 minutes
• Random urine sample provides A:C ratio in 7 minutes
• Requires no sample or reagent preparation prior to testing
• New 2-D bar-code scanner — for the DCA Vantage® Analyzer and CLINIITEK Status® Connect System
Share this page:
Complete the form below to request a demo of the DCA Vantage Analyzer.
Because of some maintenance activities, this service is not available currently.
Please try again later.
Thank you for submitting your information.
A Siemens Healthineers representative will be contacting you within 3-5 business days.
Due to technical reasons your request cannot be completed. Please try again or contact us. We apologize for the inconvenience caused.
Related Products, Services & Resources
References
1. Lenters-Westra E, Slingerland RJ. Clin Chem 2010;56(1):44.
2. Thaler LM, et al. Diabetes Care 1999;22:1415-21.
3. Miller CD, et al. Diabetes Care 2003;26:1158-63.
4. Cagliero E, et al. Diabetes Care 1999;22:1785-9.
5. GHX Market Intelligence, market data report. 4Q 2012 Report.